Market Overview
The ANZ dental biomaterials market encompasses materials used in restorative dentistry, implantology, prosthodontics, and orthodontics across both countries. Australia represents the larger share of the market given its higher per-capita dental expenditure, greater density of private dental practices, and established supply chain for advanced dental products. New Zealand's market is smaller but supported by public dental services for children and adolescents, alongside a growing private sector focused on cosmetic and implant procedures.
- •Combined market size valued at approximately $35 million in 2025
- •Projected CAGR of approximately 10.6 percent through the early 2030s
- •Australia accounts for the majority of the combined regional market value
Growth Drivers
The market growth is fueled by demographic shifts and technological adoption across the region. An aging population in both countries has increased demand for dental prosthetics and implants, as older adults experience higher rates of tooth loss and require restorative interventions. Rising consumer interest in cosmetic dentistry has further expanded the market for advanced materials such as zirconia ceramics and aesthetic composites. The increasing adoption of digital dentistry technologies, including CAD/CAM systems, intraoral scanners, and 3D-printed prosthetics, has accelerated demand for compatible and precision-engineered biomaterials.
- •Increasing edentulism and aging population drive demand for dental implants and prosthetics
- •Growing consumer demand for aesthetic dental solutions fuels adoption of ceramic and composite materials
- •Adoption of digital dentistry and CAD/CAM technologies accelerates demand for precision biomaterials
Segmentation and Regional Analysis
The market is segmented by material type, application, and geography. Ceramic biomaterials, particularly zirconia-based ceramics, represent a fast-growing segment due to their superior aesthetic properties, biocompatibility, and strength suitable for crowns and bridges. Metallic biomaterials, primarily titanium, remain dominant in implant applications due to their proven track record and osseointegration properties. By application, implantology and prosthodontics account for the largest shares, while orthodontics shows consistent growth driven by the increasing adoption of clear aligners and aesthetic orthodontic solutions.
- •Australia accounts for approximately 85 percent of the combined ANZ market value
- •New Zealand shows faster percentage growth due to its smaller existing market base
- •Implantology and prosthodontics are the dominant application segments
Trends and Outlook
What are the recent trends and outlook?
The market is expected to sustain its growth trajectory through the end of the decade, supported by ongoing investments in dental infrastructure, practitioner education, and consumer awareness campaigns. Digital dentistry integration, including intraoral scanning, CAD/CAM milling, and 3D-printed prosthetics, will continue to shape product development and drive demand for compatible biomaterials. The trend toward metal-free, biocompatible materials such as zirconia and advanced ceramics is expected to gain momentum, while regulatory emphasis on material safety and quality standards will influence product adoption. Long-term growth will be underpinned by aging demographics, rising oral health awareness, and continued public and private healthcare investment across both countries.
- •Digital dentistry adoption will drive demand for compatible and precision-engineered biomaterials
- •Zirconia and advanced ceramic-based materials expected to gain share over traditional metallic options
- •Long-term growth supported by aging demographics, cosmetic trends, and rising oral health awareness
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.